Medicure Inc has maintained a steady performance this week, reflecting its ongoing developments in the health care sector.
Medicure Inc (MPH.V) has seen its stock price hold steady this week, with a slight increase of 0.40% on the last trading day. The company, which focuses on developing innovative therapies in the health care sector, has experienced significant growth over the past month, with shares rising over 83%. This week, Medicure made headlines with news of its presentation at a major epilepsy congress, showcasing its commitment to advancing treatment options.
Advertisement
Medicure Inc
MPH.V
MPH.V
Medicure Inc
WealthAwesomeMarket cap
$31.10M
52W high
$4.95
52W low
$0.85
1W change
+26.28%
Beta
1.15
Analyst Price Targets
Based on analyst covering MPH · as of Sep 17, 2026
Wall Street analysts forecast MPH stock price to fall 24.3% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.80
-24.3% Upside
Current Price
C$3.70
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MPH's historical volatility
30-Day Vol
125.8%
Annualized
90-Day Vol
135.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$4.42
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.93 | C$2.54 – C$6.06 |
| 60 trading days | C$4.17 | C$2.26 – C$7.70 |
| 90 trading days | C$4.42 | C$2.09 – C$9.38 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the recent developments surrounding Medicure, particularly its participation in the 16th European Epilepsy Congress, as a signal of its ongoing efforts to innovate within the health care sector. The stock's strong performance over the past year may indicate positive sentiment, but investors should remain cautious given its negative profit margin and return on equity.
Medicure Inc's stock up 83.82% in the last month.
The stock has shown remarkable growth this month, reflecting investor interest and confidence in its future developments.
Bull case
Medicure's recent presentation at the European Epilepsy Congress could boost its visibility in the medical community, potentially attracting more interest and investment in its therapies. The company's strong price performance over the last year suggests that investors are optimistic about its future prospects.
Bear case
Despite recent gains, Medicure's financials show challenges, including a negative profit margin and return on equity. Investors should be cautious about the sustainability of its stock price given these financial hurdles.
Recent Price Action
Medicure Inc's stock closed at C$2.50, reflecting a modest increase of 0.40% on the last trading day. Over the past week, the stock has remained unchanged, while the month-to-date performance has been impressive with an increase of 83.82%. Year-to-date, the stock has surged by 119.30%, indicating strong investor interest.
Advertisement
Company News
On September 8, 2026, Medicure presented the design and baseline data for its MEND-PNPO Phase 3 study at the 16th European Epilepsy Congress. This presentation is significant as it highlights the company's commitment to advancing treatment options for epilepsy, potentially increasing its visibility and credibility in the health care sector.
Technical Picture
Medicure's technical indicators suggest a strong upward trend. The stock is currently trading well above its 50-day moving average of C$1.47 and its 200-day moving average of C$1.23, indicating positive momentum. The stock's 52-week range of C$0.85 to C$2.74 suggests it is currently trading at approximately 87% of its range, reflecting a solid position in the market. However, with a beta of 1.27, the stock may be more volatile compared to the broader market.
Volume Analysis
The trading volume for Medicure Inc has been relatively low, with the latest volume recorded at 225 shares, significantly below the 20-day average volume of 6,146 shares. This indicates a volume ratio of just 0.04x, suggesting limited trading activity and potential liquidity concerns.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
